Biglycan enhances gastric cancer invasion by activating FAK signaling pathway

Biglycan (BGN) is an important member of small leucine-rich proteoglycans family, and has been implicated in oncogenesis and development of various human cancer types. Here we report that BGN promotes tumor invasion and metastasis of gastric cancer both in vitro and in vivo. BGN expression is significantly higher in gastric cancer tissues and associated with lymph node metastasis, depth of tumor invasion and TNM stage. BGN enhances gastric cancer cell wound healing, migration and invasion ability as well as the tube formation ability of endothelial cells in vitro. Animal experiments results in vivo are consistent with outcomes in vitro. BGN induces increased phosphorylation of FAK (Tyr576/577, Tyr925 and Tyr397) and Paxillin. These results indicate that BGN is upregulated, and plays an oncogenic role, in gastric cancer metastasis by activating the FAK signaling pathway.

[1]  Ning Yang,et al.  Expression and significance of biglycan in endometrial cancer , 2014, Archives of Gynecology and Obstetrics.

[2]  T. Zeng,et al.  High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma. , 2013, International journal of clinical and experimental pathology.

[3]  M. Blanca Piazuelo,et al.  Gastric cáncer: Overview , 2013, Colombia medica.

[4]  A. Piga,et al.  Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma , 2013, Tumor Biology.

[5]  E. Beierle,et al.  FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma , 2012, Clinical & Experimental Metastasis.

[6]  Yuehua Gong,et al.  Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers , 2012, Clinical and Experimental Medicine.

[7]  N. Shinohara,et al.  Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells , 2012, British Journal of Cancer.

[8]  Hua-mei Tang,et al.  Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer , 2011, Experimental biology and medicine.

[9]  M. Mikuła,et al.  Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors , 2011, Functional & Integrative Genomics.

[10]  Valerie M. Weaver,et al.  The extracellular matrix at a glance , 2010, Journal of Cell Science.

[11]  J. Soria,et al.  Vasculogenic mimicry of acute leukemic bone marrow stromal cells , 2009, Leukemia.

[12]  Jihe Zhao,et al.  Signal transduction by focal adhesion kinase in cancer , 2009, Cancer and Metastasis Reviews.

[13]  C. Klein,et al.  The Metastasis Cascade , 2008, Science.

[14]  E. Bruyneel,et al.  Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion. , 2007, International journal of oncology.

[15]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[16]  D. A. Hanson,et al.  Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors , 2006, Oncogene.

[17]  W. Weichert,et al.  Polo-like kinase 1 expression is a prognostic factor in human colon cancer. , 2005, World journal of gastroenterology.

[18]  Jonathan A. Cooper,et al.  Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness. , 2005, Molecular biology of the cell.

[19]  Z. Salah,et al.  Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples , 2005, International journal of cancer.

[20]  H. Sasamura,et al.  Extracellular Matrix Glycoprotein Biglycan Enhances Vascular Smooth Muscle Cell Proliferation and Migration , 2004, Circulation research.

[21]  L. Kornberg,et al.  Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx , 2003, The Laryngoscope.

[22]  H. Kalthoff,et al.  Regulation of Biglycan Gene Expression by Transforming Growth Factor-β Requires MKK6-p38 Mitogen-activated Protein Kinase Signaling Downstream of Smad Signaling* , 2003, The Journal of Biological Chemistry.

[23]  T. Gress,et al.  Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. , 2001, Gastroenterology.

[24]  S. Hundahl,et al.  The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy , 2000, Cancer.

[25]  M. Young,et al.  Human biglycan gene. Putative promoter, intron-exon junctions, and chromosomal localization. , 1991, The Journal of biological chemistry.

[26]  H. Nemoto,et al.  TIP60 as a potential marker for the malignancy of gastric cancer. , 2011, Anticancer research.

[27]  C. Steindler,et al.  TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. , 2008, Experimental cell research.

[28]  M. Young,et al.  Regulation, regulatory activities, and function of biglycan. , 2004, Critical reviews in eukaryotic gene expression.

[29]  T. Seufferlein,et al.  Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. , 2001, Cancer research.

[30]  I. Fidler,et al.  Cancer metastasis. , 1991, British medical bulletin.